Arbutus Biopharma Corporation
DE ˙ DB ˙ CA03879J1003
3,73 € ↑0,06 (1,63%)
2026-06-04
DEL PRIS
SecurityDE:I9DN / Arbutus Biopharma Corporation
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership677,138 shares
Latest Disclosed Value $ 3,047,121
Citadel Advisors Llc ownership in I9DN / Arbutus Biopharma Corporation

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 677,138 shares of Arbutus Biopharma Corporation (DE:I9DN) valued at $2,483,742 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 104,843 shares of Arbutus Biopharma Corporation. This represents a change in shares of 545.86% during the quarter. The current value of the position is $2,525,725 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (I9DN) in the form of stock options. The firm currently holds call options representing 32,400 of underlying shares valued at $145,800 USD and put options representing 75,700 of underlying shares valued at $340,650 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:I9DN / Arbutus Biopharma Corporation Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 677,138 572,295 545.86 3,047 504.56 0.0004
2026-02-17 2025-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 104,843 -88,848 -45.87 504 -42.66 0.0001
2025-11-14 2025-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 193,691 73,419 61.04 879 136.93 0.0001
2025-08-14 2025-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 120,272 -31,142 -20.57 372 -29.73 0.0001
2025-05-15 2025-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 151,414 -126,145 -45.45 528 -41.79 0.0001
2025-02-14 2024-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 277,559 -330,185 -54.33 908 -61.22 0.0002
2024-11-14 2024-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 607,744 462,869 319.50 2,340 423.27 0.0005
2024-08-14 2024-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 144,875 -1,850,929 -92.74 448 -91.32 0.0001
2024-05-15 2024-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 1,995,804 61,846 3.20 5,149 6.52 0.0010
2024-02-14 2023-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 1,933,958 -84,219 -4.17 4,835 18.02 0.0010
2023-11-14 2023-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 2,018,177 -278,995 -12.15 4,097 -22.47 0.0009
2023-08-14 2023-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 2,297,172 2,076,034 938.80 5,283 688.51 0.0011
2023-05-15 2023-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 221,138 -145,722 -39.72 670 -21.55 0.0001
2023-02-14 2022-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 366,860 179,101 95.39 855 138.55 0.0002
2022-11-14 2022-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 187,759 105,406 127.99 358 60.54 0.0001
2022-08-15 2022-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 82,353 -280,026 -77.27 223 -79.35 0.0001
2022-05-16 2022-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 362,379 23,631 6.98 1,080 -18.00 0.0002
2022-02-14 2021-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 338,748 -2,126 -0.62 1,317 -9.92 0.0003
2021-11-15 2021-09-30 13F ARBUTUS BIOPHARMA Cmn 03879J100 340,874 229,943 207.28 1,462 335.12 0.0003
2021-08-16 2021-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 110,931 -585,412 -84.07 336 -85.51 0.0001
2021-05-21 2021-03-31 13F/A-1 ARBUTUS BIOPHARMA COM 03879J100 696,343 597,446 604.11 2,319 560.68 0.0006
2021-05-17 2021-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 696,343 597,446 2,319 0.0006
2021-02-16 2020-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 98,897 28,731 40.95 351 60.27 0.0001
2020-11-16 2020-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 70,166 -1,280,189 -94.80 219 -91.09 0.0001
2020-08-14 2020-06-30 13F ARBUTUS BIOPHARMA Cmn 03879J100 1,350,355 -1,127,764 -45.51 2,458 -1.80 0.0009
2020-05-15 2020-03-31 13F ARBUTUS BIOPHARMA Cmn 03879J100 2,478,119 2,423,126 4,406.24 2,503 1,535.95 0.0011
2020-02-14 2019-12-31 13F ARBUTUS BIOPHARMA Cmn 03879J100 54,993 43,034 359.85 153 512.00 0.0001
2019-08-14 2019-06-30 13F ARBUTUS BIOPHARMA Cmn 03879J100 11,959 -2,266 -15.93 25 -50.98 0.0000
2019-05-15 2019-03-31 13F ARBUTUS BIOPHARMA Cmn 03879J100 14,225 14,225 18.95 51 104.00 0.0000
2018-11-13 2018-09-30 13F ARBUTUS BIOPHARMA Cmn 03879J100 0 -78,617 -100.00 0 -100.00
2018-08-14 2018-06-30 13F/A-1 ARBUTUS BIOPHARMA Cmn 03879J100 78,617 13,820 21.33 574 77.16 0.0003
2018-08-10 2018-06-30 13F ARBUTUS BIOPHARMA Cmn 03879J100 78,617 13,820 574
2018-05-14 2018-03-31 13F/A-1 ARBUTUS BIOPHARMA Cmn 03879J100 64,797 35,981 124.86 324 121.92 0.0002
2018-05-11 2018-03-31 13F ARBUTUS BIOPHARMA Cmn 03879J100 64,797 35,981 324
2018-02-09 2017-12-31 13F ARBUTUS BIOPHARMA Cmn 03879J100 28,816 28,816 -55.53 146 -54.94 0.0001
2017-11-09 2017-09-30 13F ARBUTUS BIOPHARMA Cmn 03879J100 0 -14,428 -100.00 0 -100.00
2017-08-11 2017-06-30 13F ARBUTUS BIOPHARMA Cmn 03879J100 14,428 3,909 37.16 52 52.94 0.0000
2017-05-12 2017-03-31 13F ARBUTUS BIOPHARMA Cmn 03879J100 10,519 -27,629 -72.43 34 -63.44 0.0000
2017-02-10 2016-12-31 13F ARBUTUS BIOPHARMA Cmn 03879J100 38,148 38,148 262.66 93 173.53 0.0001
2017-01-31 2016-03-31 13F/A-1 ARBUTUS BIOPHARMA Cmn 03879J100 0 -269,245 -100.00 0 -100.00
2017-01-31 2015-12-31 13F/A-1 ARBUTUS BIOPHARMA Cmn 03879J100 269,245 -485,385 -64.32 1,198 -73.93 0.0013
2016-02-12 2015-12-31 13F ARBUTUS BIOPHARMA Cmn 03879J100 269,245 1,198
2015-11-16 2015-09-30 13F ARBUTUS BIOPHARMA Cmn 03879J100 754,630 754,630 4,596 0.0044
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ARBUTUS BIOPHARMA COM Call 32,400 146 n/a n/a n/a
2026-02-17 2025-12-31 13F ARBUTUS BIOPHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F ARBUTUS BIOPHARMA COM Call 30,600 -57.02 139 -37.27 n/a n/a n/a
2025-08-14 2025-06-30 13F ARBUTUS BIOPHARMA COM Call 71,200 87.86 220 66.67 n/a n/a n/a
2025-05-15 2025-03-31 13F ARBUTUS BIOPHARMA COM Call 37,900 -24.80 132 -19.51 n/a n/a n/a
2025-02-14 2024-12-31 13F ARBUTUS BIOPHARMA COM Call 50,400 -7.18 165 -21.53 n/a n/a n/a
2024-11-14 2024-09-30 13F ARBUTUS BIOPHARMA COM Call 54,300 129.11 209 186.30 n/a n/a n/a
2024-08-14 2024-06-30 13F ARBUTUS BIOPHARMA COM Call 23,700 -74.54 73 -69.58 n/a n/a n/a
2024-05-15 2024-03-31 13F ARBUTUS BIOPHARMA COM Call 93,100 -14.51 240 -11.76 n/a n/a n/a
2024-02-14 2023-12-31 13F ARBUTUS BIOPHARMA COM Call 108,900 13.20 272 39.49 n/a n/a n/a
2023-11-14 2023-09-30 13F ARBUTUS BIOPHARMA COM Call 96,200 -12.15 195 -22.31 n/a n/a n/a
2023-08-14 2023-06-30 13F ARBUTUS BIOPHARMA COM Call 109,500 -33.76 252 -49.80 n/a n/a n/a
2023-05-15 2023-03-31 13F ARBUTUS BIOPHARMA COM Call 165,300 -29.06 501 -7.75 n/a n/a n/a
2023-02-14 2022-12-31 13F ARBUTUS BIOPHARMA COM Call 233,000 6.49 543 29.67 n/a n/a n/a
2022-11-14 2022-09-30 13F ARBUTUS BIOPHARMA COM Call 218,800 2.20 418 -27.93 n/a n/a n/a
2022-08-15 2022-06-30 13F ARBUTUS BIOPHARMA COM Call 214,100 -24.16 580 -31.03 n/a n/a n/a
2022-05-16 2022-03-31 13F ARBUTUS BIOPHARMA COM Call 282,300 -21.78 841 -40.10 n/a n/a n/a
2022-02-14 2021-12-31 13F ARBUTUS BIOPHARMA COM Call 360,900 -27.24 1,404 -34.02 n/a n/a n/a
2021-11-15 2021-09-30 13F ARBUTUS BIOPHARMA Cmn Call 496,000 183.75 2,128 301.51 n/a n/a n/a
2021-08-16 2021-06-30 13F ARBUTUS BIOPHARMA COM Call 174,800 47.26 530 34.18 n/a n/a n/a
2021-05-21 2021-03-31 13F/A ARBUTUS BIOPHARMA COM Call 118,700 -2.55 395 -8.56 n/a n/a n/a
2021-05-17 2021-03-31 13F ARBUTUS BIOPHARMA COM Call 118,700 395 n/a n/a n/a
2021-02-16 2020-12-31 13F ARBUTUS BIOPHARMA COM Call 121,800 6.19 432 20.33 n/a n/a n/a
2020-11-16 2020-09-30 13F ARBUTUS BIOPHARMA COM Call 114,700 348.05 359 663.83 n/a n/a n/a
2020-08-14 2020-06-30 13F ARBUTUS BIOPHARMA Cmn Call 25,600 -77.68 47 -86.91 n/a n/a n/a
2020-05-15 2020-03-31 13F ARBUTUS BIOPHARMA Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F ARBUTUS BIOPHARMA Cmn Call 10,900 30 n/a n/a n/a
2019-05-15 2019-03-31 13F ARBUTUS BIOPHARMA Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-14 2018-12-31 13F ARBUTUS BIOPHARMA Cmn Call 16,500 63 n/a n/a n/a
2016-05-13 2016-03-31 13F ARBUTUS BIOPHARMA Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2015-12-31 13F/A ARBUTUS BIOPHARMA Cmn Call 9,600 -22.58 43 -43.42 n/a n/a n/a
2016-02-12 2015-12-31 13F ARBUTUS BIOPHARMA Cmn Call 9,600 43 n/a n/a n/a
2015-11-16 2015-09-30 13F ARBUTUS BIOPHARMA Cmn Call 12,400 -8.82 76 -52.80 n/a n/a n/a
2015-08-14 2015-06-30 13F TEKMIRA PHARMACEUTICALS Cmn Call 13,600 -8.72 161 -38.08 n/a n/a n/a
2015-05-15 2015-03-31 13F TEKMIRA PHARMACEUTICALS Cmn Call 14,900 -47.54 260 -39.53 n/a n/a n/a
2015-02-17 2014-12-31 13F TEKMIRA PHARMACEUTICALS Cmn Call 28,400 -48.74 430 -63.28 n/a n/a n/a
2014-11-14 2014-09-30 13F TEKMIRA PHARMACEUTICALS Cmn Call 55,400 1,188.37 1,171 1,991.07 n/a n/a n/a
2014-08-14 2014-06-30 13F TEKMIRA PHARMACEUTICALS Cmn Call 4,300 56 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ARBUTUS BIOPHARMA COM Put 75,700 70.11 341 58.88 n/a n/a n/a
2026-02-17 2025-12-31 13F ARBUTUS BIOPHARMA COM Put 44,500 -15.72 214 -10.46 n/a n/a n/a
2025-11-14 2025-09-30 13F ARBUTUS BIOPHARMA COM Put 52,800 45.45 240 113.39 n/a n/a n/a
2025-08-14 2025-06-30 13F ARBUTUS BIOPHARMA COM Put 36,300 41.80 112 25.84 n/a n/a n/a
2025-05-15 2025-03-31 13F ARBUTUS BIOPHARMA COM Put 25,600 -20.25 89 -14.42 n/a n/a n/a
2025-02-14 2024-12-31 13F ARBUTUS BIOPHARMA COM Put 32,100 -10.08 105 -24.09 n/a n/a n/a
2024-11-14 2024-09-30 13F ARBUTUS BIOPHARMA COM Put 35,700 19.40 137 48.91 n/a n/a n/a
2024-08-14 2024-06-30 13F ARBUTUS BIOPHARMA COM Put 29,900 -71.98 92 -66.55 n/a n/a n/a
2024-05-15 2024-03-31 13F ARBUTUS BIOPHARMA COM Put 106,700 330.24 275 343.55 n/a n/a n/a
2024-02-14 2023-12-31 13F ARBUTUS BIOPHARMA COM Put 24,800 6.90 62 31.91 n/a n/a n/a
2023-11-14 2023-09-30 13F ARBUTUS BIOPHARMA COM Put 23,200 -4.13 47 -14.55 n/a n/a n/a
2023-08-14 2023-06-30 13F ARBUTUS BIOPHARMA COM Put 24,200 100.00 56 52.78 n/a n/a n/a
2023-05-15 2023-03-31 13F ARBUTUS BIOPHARMA COM Put 12,100 -81.99 37 -76.92 n/a n/a n/a
2023-02-14 2022-12-31 13F ARBUTUS BIOPHARMA COM Put 67,200 30.74 157 59.18 n/a n/a n/a
2022-11-14 2022-09-30 13F ARBUTUS BIOPHARMA COM Put 51,400 -20.68 98 -44.32 n/a n/a n/a
2022-08-15 2022-06-30 13F ARBUTUS BIOPHARMA COM Put 64,800 -64.45 176 -67.59 n/a n/a n/a
2022-05-16 2022-03-31 13F ARBUTUS BIOPHARMA COM Put 182,300 -27.43 543 -44.42 n/a n/a n/a
2022-02-14 2021-12-31 13F ARBUTUS BIOPHARMA COM Put 251,200 13.36 977 2.73 n/a n/a n/a
2021-11-15 2021-09-30 13F ARBUTUS BIOPHARMA Cmn Put 221,600 -28.31 951 1.49 n/a n/a n/a
2021-08-16 2021-06-30 13F ARBUTUS BIOPHARMA COM Put 309,100 12.89 937 2.74 n/a n/a n/a
2021-05-21 2021-03-31 13F/A ARBUTUS BIOPHARMA COM Put 273,800 8.91 912 2.24 n/a n/a n/a
2021-05-17 2021-03-31 13F ARBUTUS BIOPHARMA COM Put 273,800 912 n/a n/a n/a
2021-02-16 2020-12-31 13F ARBUTUS BIOPHARMA COM Put 251,400 352.97 892 412.64 n/a n/a n/a
2020-11-16 2020-09-30 13F ARBUTUS BIOPHARMA COM Put 55,500 -77.92 174 -80.49 n/a n/a n/a
2017-05-12 2017-03-31 13F ARBUTUS BIOPHARMA Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-10 2016-12-31 13F ARBUTUS BIOPHARMA Cmn Put 37,500 228.95 92 135.90 n/a n/a n/a
2017-01-31 2016-09-30 13F/A ARBUTUS BIOPHARMA Cmn Put 11,400 -69.60 39 -57.61 n/a n/a n/a
2016-11-10 2016-09-30 13F ARBUTUS BIOPHARMA Cmn Put 11,400 39 n/a n/a n/a
2017-01-31 2016-03-31 13F/A ARBUTUS BIOPHARMA Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2015-12-31 13F/A ARBUTUS BIOPHARMA Cmn Put 9,600 -21.31 43 -41.89 n/a n/a n/a
2016-02-12 2015-12-31 13F ARBUTUS BIOPHARMA Cmn Put 9,600 43 n/a n/a n/a
2015-11-16 2015-09-30 13F ARBUTUS BIOPHARMA Cmn Put 12,200 -50.61 74 -74.74 n/a n/a n/a
2015-08-14 2015-06-30 13F TEKMIRA PHARMACEUTICALS Cmn Put 24,700 -23.53 293 -48.05 n/a n/a n/a
2015-05-15 2015-03-31 13F TEKMIRA PHARMACEUTICALS Cmn Put 32,300 420.97 564 500.00 n/a n/a n/a
2015-02-17 2014-12-31 13F TEKMIRA PHARMACEUTICALS Cmn Put 6,200 -84.88 94 -89.16 n/a n/a n/a
2014-11-14 2014-09-30 13F TEKMIRA PHARMACEUTICALS Cmn Put 41,000 540.62 867 932.14 n/a n/a n/a
2014-08-14 2014-06-30 13F TEKMIRA PHARMACEUTICALS Cmn Put 6,400 84 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.